Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mario C Deng

Showing results (21-30 of 109) with videos related to

Pageof 11
Sort By:
Atherosclerosis|December 17, 2002
Vascular collagens: spotlight on the role of type VIII collagen in atherogenesisGabriele A M Plenz, Mario C Deng, Horst Robenek, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|March 31, 2015
Reduced HLA Class II antibody response to proteasome inhibition in heart transplantationTam Khuu, Martin Cadeiras, Nicholas Wisniewski, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|June 16, 2004
Surrogate markers for late cardiac allograft survivalMandeep R Mehra, Ray Benza, Mario C Deng, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|March 6, 2010
Relationship between prolonged QTc interval, cardiac allograft dysfunction and elevated molecular gene expression profiling test score after heart transplantationKhurram Shahzad, Junkit He, Qiaoyi Li, et al.
Journal of Molecular and Cellular Cardiology|April 17, 2014
S-nitrosylation of TRIM72 mends the broken heart: a molecular modifier-mediated cardioprotectionC Y X'avia Chan, Ding Wang, Martin Cadeiras, et al.
Cardiology Research and Practice|July 31, 2010
Unexplained Graft Dysfunction after Heart Transplantation-Role of Novel Molecular Expression Test Score and QTc-Interval: A Case ReportKhurram Shahzad, Martin Cadeiras, Kotaro Arai, et al.
Cardiology Clinics|November 30, 2013
Management of ACCF/AHA Stage C heart failureSasikanth Adigopula, Rey P Vivo, Eugene C DePasquale, et al.
Clinical and Translational Medicine|May 12, 2017
Anthracycline induced cardiotoxicity: biomarkers and "Omics" technology in the era of patient specific careShayan Moazeni, Martin Cadeiras, Eric H Yang, et al.
Expert Review of Cardiovascular Therapy|August 16, 2013
Obesity in heart failure: impact on survival and treatment modalitiesRichard K Cheng, Eugene C DePasquale, Mario C Deng, et al.
The Journal of Thoracic and Cardiovascular Surgery|December 11, 2003
Should HIV-positive recipients undergo heart transplantation?Gianluigi Bisleri, Jeffrey A Morgan, Mario C Deng, et al.
Pageof 11

Showing results (21-30 of 109) with videos related to

Sort By:
Pageof 11
Atherosclerosis|December 17, 2002
Vascular collagens: spotlight on the role of type VIII collagen in atherogenesisGabriele A M Plenz, Mario C Deng, Horst Robenek, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|March 31, 2015
Reduced HLA Class II antibody response to proteasome inhibition in heart transplantationTam Khuu, Martin Cadeiras, Nicholas Wisniewski, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|June 16, 2004
Surrogate markers for late cardiac allograft survivalMandeep R Mehra, Ray Benza, Mario C Deng, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|March 6, 2010
Relationship between prolonged QTc interval, cardiac allograft dysfunction and elevated molecular gene expression profiling test score after heart transplantationKhurram Shahzad, Junkit He, Qiaoyi Li, et al.
Journal of Molecular and Cellular Cardiology|April 17, 2014
S-nitrosylation of TRIM72 mends the broken heart: a molecular modifier-mediated cardioprotectionC Y X'avia Chan, Ding Wang, Martin Cadeiras, et al.
Cardiology Research and Practice|July 31, 2010
Unexplained Graft Dysfunction after Heart Transplantation-Role of Novel Molecular Expression Test Score and QTc-Interval: A Case ReportKhurram Shahzad, Martin Cadeiras, Kotaro Arai, et al.
Cardiology Clinics|November 30, 2013
Management of ACCF/AHA Stage C heart failureSasikanth Adigopula, Rey P Vivo, Eugene C DePasquale, et al.
Clinical and Translational Medicine|May 12, 2017
Anthracycline induced cardiotoxicity: biomarkers and "Omics" technology in the era of patient specific careShayan Moazeni, Martin Cadeiras, Eric H Yang, et al.
Expert Review of Cardiovascular Therapy|August 16, 2013
Obesity in heart failure: impact on survival and treatment modalitiesRichard K Cheng, Eugene C DePasquale, Mario C Deng, et al.
The Journal of Thoracic and Cardiovascular Surgery|December 11, 2003
Should HIV-positive recipients undergo heart transplantation?Gianluigi Bisleri, Jeffrey A Morgan, Mario C Deng, et al.
Pageof 11